To evaluate the clinical relevance of PYCR1 in breast cancer patients, we validated the expression of PYCR1 and downstream cGMP-PKG components and predicted their prognosis using The Cancer Genome Atlas (TCGA) database. This evidence concerns the gene PYCR1 and breast cancer.